Microbiome and pediatric atopic dermatitis

Journal of Dermatology

Volumn 42, Issue 12, 2015, Pages 1137-1142

  Powers, Claire E ^a   McShane, Diana B ^b   Gilligan, Peter H ^c   Burkhart, Craig N ^b   Morrell, Dean S ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

antimicrobial cationic peptides; atopic dermatitis; microbiota; probiotics; Staphylococcus aureus

Indexed keywords

DEXAMETHASONE; PROBIOTIC AGENT;

ATOPIC DERMATITIS; BACTERIAL COLONIZATION; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BREVE; DISEASE COURSE; DRUG EFFICACY; HUMAN; LACTOBACILLUS PARACASEI; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS SALIVARIUS; MICROBIOME; NONHUMAN; PATHOGENESIS; PEDIATRICS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STAPHYLOCOCCUS AUREUS; CHILD; COMPLICATION; DERMATITIS, ATOPIC; ISOLATION AND PURIFICATION; MICROBIOLOGY; MICROFLORA; PATHOGENICITY; SKIN; STAPHYLOCOCCAL SKIN INFECTION;

CHILD; DERMATITIS, ATOPIC; HUMANS; MICROBIOTA; PROBIOTICS; SKIN; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84955182909     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/1346-8138.13072     Document Type: Review

References (55)

1. Williams H, Robertson C, Stewart A, et al,. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 1999; 103: 125-138.
2. Flohr C, Mann J,. New insights into the epidemiology of childhood atopic dermatitis. Allergy 2014; 69: 3-16.
3. Carroll CL, Balkrishnan R, Feldman SR, Fleischer AB Jr, Manuel JC,. The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol 2005; 22: 192-199.
4. Mancini AJ, Kaulback K, Chamlin SL,. The socioeconomic impact of atopic dermatitis in the United States: a systematic review. Pediatr Dermatol 2008; 25: 1-6.
5. Grice EA, Kong HH, Conlan S, et al,. Topographical and temporal diversity of the human skin microbiome. Science 2009; 324: 1190-1192.
6. Irvine AD, McLean WH, Leung DY,. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 2011; 365: 1315-1327.
7. Baurecht H, Irvine AD, Novak N, et al,. Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data. J Allergy Clin Immunol 2007; 120: 1406-1412.
8. Dominguez-Bello MG, Costello EK, Contreras M, et al,. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A 2010; 107: 11971-11975.
9. Human Microbiome Project C. Structure. function and diversity of the healthy human microbiome. Nature 2012; 486: 207-214.
10. Nomura I, Gao B, Boguniewicz M, Darst MA, Travers JB, Leung DY,. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol 2003; 112: 1195-1202.
11. Otto M,. Staphylococcus epidermidis-the 'accidental' pathogen. Nat Rev Microbiol 2009; 7: 555-567.
12. Braff MH, Bardan A, Nizet V, Gallo RL,. Cutaneous defense mechanisms by antimicrobial peptides. J Invest Dermatol 2005; 125: 9-13.
13. Ong PY, Ohtake T, Brandt C, et al,. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002; 347: 1151-1160.
14. Naik S, Bouladoux N, Wilhelm C, et al,. Compartmentalized control of skin immunity by resident commensals. Science 2012; 337: 1115-1119.
15. Neaville WA, Tisler C, Bhattacharya A, et al,. Developmental cytokine response profiles and the clinical and immunologic expression of atopy during the first year of life. J Allergy Clin Immunol 2003; 112: 740-746.
16. Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M,. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001; 108: 516-520.
17. Dom S, Droste JH, Sariachvili MA, et al,. Pre- and post-natal exposure to antibiotics and the development of eczema, recurrent wheezing and atopic sensitization in children up to the age of 4 years. Clin Exp Allergy 2010; 40: 1378-1387.
18. Benn CS, Melbye M, Wohlfahrt J, Bjorksten B, Aaby P,. Cohort study of sibling effect, infectious diseases, and risk of atopic dermatitis during first 18 months of life. BMJ 2004; 328: 1223.
19. Cramer C, Link E, Bauer CP, et al,. Association between attendance of day care centres and increased prevalence of eczema in the German birth cohort study LISAplus. Allergy 2011; 66: 68-75.
20. Hagerhed-Engman L, Bornehag CG, Sundell J, Aberg N,. Day-care attendance and increased risk for respiratory and allergic symptoms in preschool age. Allergy 2006; 61: 447-453.
21. Phipatanakul W,. Endotoxin Exposure and Eczema in the First Year of Life. Pediatrics 2004; 114: 13-18.
22. Gehring U, Bolte G, Borte M, et al,. Exposure to endotoxin decreases the risk of atopic eczema in infancy: a cohort study. J Allergy Clin Immunol 2001; 108: 847-854.
23. Gillespie J, Wickens K, Siebers R, et al,. Endotoxin exposure, wheezing, and rash in infancy in a New Zealand birth cohort. J Allergy Clin Immunol 2006; 118: 1265-1270.
24. Bolte G, Bischof W, Borte M, Lehmann I, Wichmann HE, Heinrich J,. Early endotoxin exposure and atopy development in infants: results of a birth cohort study. Clin Exp Allergy 2003; 33: 770-776.
25. Mpairwe H, Webb EL, Muhangi L, et al,. Anthelminthic treatment during pregnancy is associated with increased risk of infantile eczema: randomised-controlled trial results. Pediatr Allergy Immunol 2011; 22: 305-312.
26. Cooper PJ, Chico ME, Vaca MG, et al,. Effect of albendazole treatments on the prevalence of atopy in children living in communities endemic for geohelminth parasites: a cluster-randomised trial. Lancet 2006; 367: 1598-1603.
27. Negele K, Heinrich J, Borte M, et al,. Mode of delivery and development of atopic disease during the first 2 years of life. Pediatr Allergy Immunol 2004; 15: 48-54.
28. Bager PWJ,. Westergaard T Cesarean delivery and risk of atopy and allergic disease: Meta-analysis. Clin Exp Allergy 2008; 38: 634-642.
29. Kong HH, Oh J, Deming C, et al,. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res 2012; 22: 850-859.
30. Seite S, Flores GE, Henley JB, et al,. Microbiome of affected and unaffected skin of patients with atopic dermatitis before and after emollient treatment. J Drugs Dermatol 2014; 13: 1365-1372.
31. Wang M, Karlsson C, Olsson C, et al,. Reduced diversity in the early fecal microbiota of infants with atopic eczema. J Allergy Clin Immunol 2008; 121: 129-134.
32. Adlerberth I, Strachan DP, Matricardi PM, et al,. Gut microbiota and development of atopic eczema in 3 European birth cohorts. J Allergy Clin Immunol 2007; 120: 343-350.
33. Christophers E, Henseler T,. Contrasting disease patterns in psoriasis and atopic dermatitis. Arch Dermatol Res 1987; 279 (Suppl): S48-S51.
34. Birnie AJ, Bath-Hextall FJ, Ravenscroft JC, Williams HC,. Interventions to reduce Staphylococcus aureus in the management of atopic eczema. Cochrane Database Syst Rev 2008; (3): Cd003871.
35. Hanifin JM, Rogge JL,. Staphylococcal infections in patients with atopic dermatitis. Arch Dermatol 1977; 113: 1383-1386.
36. McFadden JP, Noble WC, Camp RD,. Superantigenic exotoxin-secreting potential of staphylococci isolated from atopic eczematous skin. Br J Dermatol 1993; 128: 631-632.
37. Macias ES, Pereira FA, Rietkerk W, Safai B,. Superantigens in dermatology. J Am Acad Dermatol 2011; 64: 455-472; quiz 73-4.
38. Leung DY,. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 2000; 105: 860-876.
39. Stalder JF, Fleury M, Sourisse M, Rostin M, Pheline F, Litoux P,. Local steroid therapy and bacterial skin flora in atopic dermatitis. Br J Dermatol 1994; 131: 536-540.
40. White MI, Noble WC,. The cutaneous reaction to staphylococcal protein A in normal subjects and patients with atopic dermatitis or psoriasis. Br J Dermatol 1985; 113: 179-183.
41. Higaki S, Morohashi M, Yamagishi T, Hasegawa Y,. Comparative study of staphylococci from the skin of atopic dermatitis patients and from healthy subjects. Int J Dermatol 1999; 38: 265-269.
42. Darabi K, Hostetler SG, Bechtel MA, Zirwas M,. The role of Malassezia in atopic dermatitis affecting the head and neck of adults. J Am Acad Dermatol 2009; 60: 125-136.
43. Betsi GI, Papadavid E, Falagas ME,. Probiotics for the treatment or prevention of atopic dermatitis: a review of the evidence from randomized controlled trials. Am J Clin Dermatol 2008; 9: 93-103.
44. Boyle RJ, Bath-Hextall FJ, Leonardi-Bee J, Murrell DF, Tang ML,. Probiotics for treating eczema. Cochrane Database Syst Rev 2008; (4): Cd006135.
45. Lee J, Seto D, Bielory L,. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol 2008; 121: 116-21.e11.
46. Wickens K, Black P, Stanley TV, et al,. A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years. Clin Exp Allergy 2012; 42: 1071-1079.
47. American College of Allergy AIA. Abstracts P328 and P329. Presented November 8, 2014.
48. Mohammedsaeed W, McBain AJ, Cruickshank SM, O'Neill CA,. Lactobacillus rhamnosus GG inhibits the toxic effects of Staphylococcus aureus on epidermal keratinocytes. Appl Environ Microbiol 2014; 80: 5773-5781.
49. Elias PM, Steinhoff M,. "Outside-to-inside" (and now back to "outside") pathogenic mechanisms in atopic dermatitis. J Invest Dermatol 2008; 128: 1067-1070.
50. Grice EA, Segre JA,. The skin microbiome. Nat Rev Microbiol 2011; 9: 244-253.
51. Yang HJ, Min TK, Lee HW, Pyun BY,. Efficacy of probiotic therapy on atopic dermatitis in children: a randomized, double-blind, placebo-controlled trial. Allergy Asthma Immunol Res 2014; 6: 208-215.
52. Han Y, Kim B, Ban J, et al,. A randomized trial of Lactobacillus plantarum CJLP133 for the treatment of atopic dermatitis. Pediatr Allergy Immunol 2012; 23: 667-673.
53. Gore C, Custovic A, Tannock GW, et al,. Treatment and secondary prevention effects of the probiotics Lactobacillus paracasei or Bifidobacterium lactis on early infant eczema: randomized controlled trial with follow-up until age 3 years. Clin Exp Allergy 2012; 42: 112-122.
54. Wu KG, Li TH, Peng HJ,. Lactobacillus salivarius plus fructo-oligosaccharide is superior to fructo-oligosaccharide alone for treating children with moderate to severe atopic dermatitis: a double-blind, randomized, clinical trial of efficacy and safety. Br J Dermatol 2012; 166: 129-136.
55. van der Aa LB, Lutter R, Heymans HS, et al,. No detectable beneficial systemic immunomodulatory effects of a specific synbiotic mixture in infants with atopic dermatitis. Clin Exp Allergy 2012; 42: 531-539.